Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus

NCT ID: NCT05212298

Last Updated: 2025-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-16

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project is planned to collect non-dialysis adults who suffer from sleep and tinnitus disorders and refuse to take sleeping medicines in our hospital by random assignment and double-blind method.

120 adults were divided into 3 groups.

1. Control group: receive placebo treatment, once a day, four pills each time.
2. Herbal compound low-dose group: once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 557 mg.
3. Herbal compound high-dose group: once a day, four capsules each time. The total amount of herbal compound capsules is 1114 mg.

All subjects received health questionnaire, sleep questionnaire and tinnitus questionnaire before the start of the test At the end of the treatment(3 months), the health questionnaire, sleep questionnaire, and tinnitus questionnaire were accepted.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sleep disturbances were very popular in general population. The prevalence of sleep disturbances were about 20 \~30% in adults. Insomnia is a complex disease with many etiologies. For example, pressure from daily activity, psychiatric diseases, and organic diseases may contribute to sleep disturbances. Besides, insomnia often comorbid comorbidly with tinnitus, and form a vicious cycle between insomnia and tinnitus. In the aspect of treatment, besides psychological treatment, insomnia was often treated with hypnotics. Variable types of GABA agonists and/or antidepression agents, including selective serotonin reuptake inhibitor (SSRI) were often used for insomnia. However, the medical treatments for insomnia patients were unsatisfactory, and many patients search for traditional Chinese medicine and/or herbal medicine.

Tinnitus can be defined as a phantom auditory perception in the absence of an external sound source. It is a common auditory symptom with a prevalence ranges from 4.6% in a survey study in Iranian population to 25.3% in a nationally representative survey in the United States, depending on the definition of tinnitus and study populations. A recent nationwide survey of the general population of South Korea reported that the prevalence of any tinnitus was 20.7% among adults aged 20 to 98 years. The prevalence was higher in women and it increased with age. A cohort study in England indicated that the incidence of clinically significant tinnitus was 5.4 cases per 10,000 person-years.

Tinnitus can severely interfere with activities of daily living, with common comorbidities such as anxiety, irritability, depression, inability to concentration, and sleep disturbances. Studies based on both questionnaires and polysomnography reported that sleep disturbance are common in patients with tinnitus. Recently, the investigators found that the risk of tinnitus was increased in middle-aged and elderly patients with sleep disturbance and/or sleep apnea. In the aspect of treatment, GABA agonists were often used to for tinnitus, but the results are still unsatisfactory till now.

Since many years ago, traditional Chinese medicine or herbal medicine had take care of insomnia and tinnitus. Some herbal foods and/or drugs, for example Lemon Balm Extract、Rice bran fermentation extract (GABA)、L-Tryptophan, were suggested for these two diseases with various results. In this study ,the investigators aimed to investigate the effects of herbal sleep formula on the sleep and tinnitus of patients without hemodialysis or peritoneal dialysis.

This project is planned to collect non-dialysis adults who suffer from sleep and tinnitus disorders and refuse to take sleeping medicines in our hospital by random assignment and double-blind method.

120 adults were divided into 3 groups.

1. Control group: receive placebo treatment, once a day, four pills each time.
2. Herbal compound low-dose group: once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 557 mg.
3. Herbal compound high-dose group: once a day, four capsules each time. The total amount of herbal compound capsules is 1114 mg.

All subjects received health questionnaire, sleep questionnaire and tinnitus questionnaire before the start of the test At the end of the treatment(3 months), the health questionnaire, sleep questionnaire, and tinnitus questionnaire were accepted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disturbances Tinnitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

receive placebo treatment, once a day, four pills each time.

Group Type PLACEBO_COMPARATOR

The gel contains a mixture of glucose and maltodextrin

Intervention Type DIETARY_SUPPLEMENT

The gel contains a mixture of glucose and maltodextrin - a complex carbohydrate - along with fat and a trace of protein.

Herbal compound low-dose

once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 557 mg.

Group Type EXPERIMENTAL

Herbal compound low-dose

Intervention Type DIETARY_SUPPLEMENT

The total amount of herbal compound capsules is 557 mg.

Herbal compound high-dose

once a day, four capsules each time. The total amount of herbal compound capsules is 1114 mg.

Group Type EXPERIMENTAL

Herbal compound high-dose

Intervention Type DIETARY_SUPPLEMENT

The total amount of herbal compound capsules is 1114 mg.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The gel contains a mixture of glucose and maltodextrin

The gel contains a mixture of glucose and maltodextrin - a complex carbohydrate - along with fat and a trace of protein.

Intervention Type DIETARY_SUPPLEMENT

Herbal compound low-dose

The total amount of herbal compound capsules is 557 mg.

Intervention Type DIETARY_SUPPLEMENT

Herbal compound high-dose

The total amount of herbal compound capsules is 1114 mg.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 20\~70 years old
2. Non-dialysis patients
3. Suffering from sleep disorders and tinnitus
4. Refuse to take sleeping pills

Exclusion Criteria

1. Patients who are bedridden or unable to take care of themselves.
2. dialysis patients.
3. Patients who cannot understand the details of this study or cannot cooperate with the examination.
4. History of alcohol or drug abuse.
5. Pregnant and lactating women
6. Patients with moderate to severe sleep apnea
7. Take sleeping pills
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dalin Tzu Chi General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juen-Haur Hwang, MD, PhD.

Role: STUDY_CHAIR

Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Chiayi City, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Juen-Haur Hwang, MD, PhD.

Role: CONTACT

+886-5-2648000 ext. 5329

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Juen-Haur Hwang, MD, PhD

Role: primary

+886-5-2648000 ext. 5239

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A10804001-3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Green Tea Extract and Ginger
NCT07150533 COMPLETED NA